GEn1E Lifesciences Investor
GEn1E has developed a unique technology platform for treating rare and inflammatory diseases, with a particular focus on Next Generation substrate-specific p38α kinase /?
Invests into
Headquarters:
Palo Alto, California, United States
Founded Date:
2018.0
Industry:
Healthcare Company
Estimated Revenue:
$1.8M
Technology:
Biotechnology, Heath and Wellness Technology